Source link : https://www.newshealth.biz/health-news/study-statins-mitigate-heart-risks-from-jak-inhibitors/
WASHINGTON — Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) may not have to worry so much about increased cardiovascular risk — if they’re taking statins, research presented here suggested. Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using statins, major adverse cardiovascular events […]
Author : News Health
Publish date : 2024-11-18 18:13:08
Copyright for syndicated content belongs to the linked Source.